Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DENND6A divergent transcript (DENND6A-DT) is a long non-coding RNA (lncRNA) gene located near and transcribed in a divergent orientation from the protein-coding DENND6A gene. LncRNAs such as DENND6A-DT are typically non-protein-coding transcripts, and the scientific literature generally classifies "divergent transcripts" as a widespread transcriptional phenomenon where noncoding RNAs are produced from gene promoters in the opposite orientation to protein-coding genes[1]. There is no published evidence that DENND6A-DT encodes a protein or directly acts as a receptor, transporter, or enzyme. Its function, if any, remains unknown, and it has not been implicated as a canonical therapeutic target, biomarker, or drug target in current genomic and biomedical databases[5]. In general, many such divergent transcripts may play regulatory roles or may simply be a byproduct of transcriptional activity[1], but for DENND6A-DT specifically, there are no data linking it to biological function, disease, or pharmacology.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DENND6A divergent transcript (DENND6A-DT).